Midazolam maleate, a water soluble 1,4 benzodiazepine, was used intravenously in 20 patients suffering seizures, of whom 12 were in status epilepticus. In all cases, midazolam in a dose of 2-5-15 mg rapidly terminated the seizure. There were no complications from the use of midazolam. The causes of the seizures were varied but alcohol-withdrawal seizures were the single largest cause. Thirteen patients were taking some form of anticonvulsant medication but only three were in the therapeutic range. Midazolam is seen to be an effective agent in the emergency treatment of seizures.
INTRODUCTION
Tonic-clonic seizures are a neurological emergency and need to be terminated quickly. Status epilepticus is defined as a seizure lasting more than 30 min or where a normal alert state is not regained between seizures. Clinical and experimental studies show that it is important to terminate tonic-clonic status epilepticus as soon as possible as it has been associated with brain damage and death (Delgado-Escueta et al., 1982) .
Benzodiazepines in seizure control
Many sedatives, tranquillizers and anaesthetic agents have been shown to terminate seizures. In the 1920s, barbiturates became established as potent anti-convulsant agents. Naquet et al. (1965) reported the successful use of diazepam in experimental animals and man. Gastaut et al. (1965) published their results of the clinical use of diazepam in terminating seizures and from that time diazepam has been used extensively. The place of diazepam in seizure control was reviewed by Delgado-Escueta et al. (1982) . Two other benzodiazepines, clonazepam and lorazepam have been used in 170 G. M. Galvin and G. A. J elinek seizure control. Clonazepam is effective as an oral agent in myoclonic epilepsy and has been used intravenously in status epilepticus (Davidson, 1980) . Lorazepam has a longer half-life than diazepam and has been used in the control of refractory neonatal seizures (Deshmukh et al., 1986) . All benzodiazepines appear to modify excitability of neuronal membranes by binding to specific receptor sites. The major effect of benzodiazepines in seizures is potentiation of the GABA (inhibitory) pathway (Meldrum & Chapman, 1986; Sunao et al., 1983) .
Diazepam has a long elimination half-life, (21-37 h), is water insoluble and requires organic solvents to remain in solution. These solvents cause venous irritation and thrombophlebitis (Brown et al., 1979) .
Recently, a water-soluble 1,4 benzodiazepine, midazolam, has become available for clinical use in Australia. Midazolam has an elimination-phase half-life of approximately 2 h and 30-40% of a single I.V. dose is recovered in a conjugated form in the urine in the first 12 h. The effect of midazolam on E.E.G. recordings is similar to that of diazepam and Brown et al. (1979) suggested that the anticonvulsant properties of diazepam and midazolam would be similar and recommended further study to clarify these points. Midazolam has been shown to protect mice from local-anaestheticinduced convulsions (Dejong & Bonin, 1981) . A case report in 1983 showed that midazolam was effective in controlling status epilepticus in a 14-year-old girl (Sunao et al., 1983) . This trial was designed to test the efficacy of midazolam in seizure control.
MATERIAL AND METHODS
Twenty adult patients (13 years and over) who suffered seizures in the emergency department or who arrived in status epilepticus were treated with intravenous midazolam. An initial dose of midazolam of 2-5 mg was followed by increments until the seizure was controlled. Blood was drawn from patients for blood alcohol and serum anticonvulsant levels. 
RESULTS
Control of seizures was achieved in less than one minute in all 20 patients, of whom 12 were in status epilepticus.
172 G. M. Galvin and G. A. Jelinek No patient suffered any significant cardio-respiratory depression. Of the 13 patients taking anticonvulsants, only three had serum levels in the therapeutic range. One patient was in the toxic range for phenytoin and intoxicated with alcohol (patient 20) (Table 1) .
DISCUSSION
Previous studies have suggested that midazolam would share anticonvulsant properties with diazepam. In this study, midazolam has been shown to be an effective agent for emergency seizure control. It was effective over a wide range of ages (20-74 years) and weights (26-120 kg). The effective dose of midazolam lay between 2 5 and 15 mg with a mean dose of 8-25 mg.
Further studies are being undertaken.
